KR890013015A - 복소환 화합물 및 항궤양제 - Google Patents

복소환 화합물 및 항궤양제 Download PDF

Info

Publication number
KR890013015A
KR890013015A KR1019890001943A KR890001943A KR890013015A KR 890013015 A KR890013015 A KR 890013015A KR 1019890001943 A KR1019890001943 A KR 1019890001943A KR 890001943 A KR890001943 A KR 890001943A KR 890013015 A KR890013015 A KR 890013015A
Authority
KR
South Korea
Prior art keywords
optionally substituted
compound
different
same
substituent
Prior art date
Application number
KR1019890001943A
Other languages
English (en)
Other versions
KR950008313B1 (ko
Inventor
시게루 마쓰따니
유끼오 미즈시마
Original Assignee
요시또시 가즈오
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시또시 가즈오, 시오노기세이야꾸 가부시끼가이샤 filed Critical 요시또시 가즈오
Publication of KR890013015A publication Critical patent/KR890013015A/ko
Application granted granted Critical
Publication of KR950008313B1 publication Critical patent/KR950008313B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음.

Description

복소환 화합물 및 항궤양제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 하기 일반식(Ⅰ)의 화합물 또는 그의 제약학상 허용 가능한 산부가염.
    [식중, R1및 R2는 각각 동일하거나 다르며, 수소, C1∼C4알킬, 시아노, 테트라졸릴, 카르복시 또는 C1∼C4알킬옥시카르보닐이고; X 및 Z는 각각 동일하거나 다르며, CH 또는 N이고; Y는 C1∼C4알킬티오, -CH2SAr, -S-S-Ar, -SCOR3, -SCH2R3또는 -SC(=NOH)Ar(Ar은 임의로 치환된 페닐, 임의로 치환된 티에닐 또는 C1∼C4알킬옥시카르보닐이고; R3은또는 -NR6R7(P, Q 및 W중 어느 것에 결합될 수 있는 R4및 R5는 각각 동일하거나 다르며, 수소, 임의로 치환된 C1∼C4알킬 또는 임의로 치환된 페닐이거나 R4및 R5가 함께 축합 벤젠 고리를 형성할 수 있으며; P 및 Q는 각각 동일하거나 다르며, C1∼C4알킬렌이고; W는 단일 결합 또는 -O-, -S- 또는 임의로 치환된 -NH-이고; R6및 R7은 각각 동일하거나 다르며, C1∼C4알킬이다(단 Y가 -SCONR6R7일 때 R1은 수소이어야 하며 R2는 테트라 졸릴 또는 시아노이어야 한다))이다)이다].
  2. 제1항에 있어서, 임의로 치환된 페닐 중 치환체가 할로겐, C1∼C4알콕시, C1∼C4알콕시카르보닐, 시아노, 니트로 및 트리플루오로메틸로 이루어진 군에서 선택된 하나 또는 두개의 종인 화합물.
  3. 제1항에 있어서, 임의로 치환된 티에닐 중 치환체가 C1∼C4아킬인 화합물.
  4. 제1항에 있어서, 치환체가 할로겐, 이소프로필카르바 모일 또는 메틸렌디옥시로 치환될 수 있는 페닐인 화합물.
  5. 제1항에 있어서, 임의로 치환된 -NH-중 치환체가 R4또는 R5인 화합물.
  6. 유효성분으로서 제1항에 따른 화합물을 약리학상 유효한 양으로 함유함을 특징으로 하는 항궤양제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890001943A 1988-02-18 1989-02-18 복소환 화합물 및 항궤양제 KR950008313B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP63-36130 1988-02-18
JP3613088 1988-02-18
JP036130/88 1988-02-18

Publications (2)

Publication Number Publication Date
KR890013015A true KR890013015A (ko) 1989-09-20
KR950008313B1 KR950008313B1 (ko) 1995-07-27

Family

ID=12461201

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890001943A KR950008313B1 (ko) 1988-02-18 1989-02-18 복소환 화합물 및 항궤양제

Country Status (9)

Country Link
US (1) US4927829A (ko)
EP (1) EP0329126B1 (ko)
JP (1) JP2668259B2 (ko)
KR (1) KR950008313B1 (ko)
AT (1) ATE109780T1 (ko)
AU (1) AU615033B2 (ko)
CA (1) CA1329389C (ko)
DE (1) DE68917333T2 (ko)
ES (1) ES2061749T3 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
DE10050661A1 (de) 2000-10-13 2002-04-18 Gruenenthal Gmbh Substituierte 3,4-Dihydro-pyrimido[1,2-a]pyrimidine und 3,4-Dihydro-pyrazino[1,2-a]pyrimidine
MXPA05003607A (es) * 2002-10-04 2005-11-17 Prana Biotechnology Ltd Compuestos neurologicamente activos.
US7767335B2 (en) * 2003-05-16 2010-08-03 The United States Of America As Represented By The Secretary Of The Navy High-voltage battery switch
WO2008074068A1 (en) * 2006-12-20 2008-06-26 Prana Biotechnology Limited Substituted quinoline derivatives as antiamyloidogeneic agents
JP2021523933A (ja) * 2018-04-20 2021-09-09 バージニア・テック・インテレクチュアル・プロパティーズ・インコーポレイテッドＶｉｒｇｉｎｉａ Ｔｅｃｈ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｉｅｓ， Ｉｎｃ． ミトコンドリア脱共役剤として有用なイミダゾピリジン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59802A (en) * 1979-05-08 1983-07-31 Erba Farmitalia Substituted pyrido(1,2-a)pyrimidine carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
AU588917B2 (en) * 1985-09-25 1989-09-28 Shionogi & Co., Ltd. 9-(substituted thio)-4h-pryido(1,2-a) pyrimidin-4-one derivatives

Also Published As

Publication number Publication date
JPH01308279A (ja) 1989-12-12
CA1329389C (en) 1994-05-10
ES2061749T3 (es) 1994-12-16
EP0329126B1 (en) 1994-08-10
AU2993789A (en) 1989-08-24
JP2668259B2 (ja) 1997-10-27
AU615033B2 (en) 1991-09-19
ATE109780T1 (de) 1994-08-15
KR950008313B1 (ko) 1995-07-27
DE68917333T2 (de) 1995-03-09
EP0329126A1 (en) 1989-08-23
DE68917333D1 (de) 1994-09-15
US4927829A (en) 1990-05-22

Similar Documents

Publication Publication Date Title
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
DE69118082D1 (de) Imidazolderivate, starke und selektive Angiotensin-II-Rezeptor-Antagonisten
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
FR2800375B1 (fr) Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
EP0269574A3 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
ATE129714T1 (de) Heterocyclische biphosphonsäurederivate.
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
ATE197710T1 (de) Chinazolin-derivate
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
EP0371805A3 (en) Piperidine derivatives and hypotensives containing the same
KR890013015A (ko) 복소환 화합물 및 항궤양제
DE69839753D1 (de) 2-(Arylphenyl)amino-imidazolin-Derivate
MX9206930A (es) Nuevos compuestos
ATE73795T1 (de) Thioformamid-derivate.
KR890012973A (ko) 이미다졸 유도체
DK378087A (da) Tetracycliske indolderivater
DK0377532T3 (da) Thioformamidderivater
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
DE60009932D1 (de) 5-aminoalkyl- und 5-aminocarbonylsubstituierte indole

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee